Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: A modular phase I trial in androgen-independent prostate cancer: Mathew P, Thall PF, Jones D, Perez C, Bucana C, Troncoso P, Kim SJ, Fidler IJ, Logothetis C., Department of Genitourinary Medical Oncology, Unit 427, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX. J Clin Oncol 2004;22:3323–9

✍ Scribed by Gurkamal Chatta

• Book ID: 116955677
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 45 KB
• Volume: 22
• Category: Article
• ISSN: 1078-1439
• DOI: 10.1016/j.urolonc.2004.09.005